NPR News Now - NPR News: 11-14-2025 2PM EST

Episode Date: November 14, 2025

NPR News: 11-14-2025 2PM ESTLearn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy...

Transcript
Discussion (0)
Starting point is 00:00:00 Lie from NPR News, I'm Lakshmi Singh. The 2020 election interference case against President Trump and allies in Georgia has a new prosecutor. Peter Skandalakis, executive director of the prosecuting attorney's counsel of Georgia, is taking over from Fulton County District Attorney Fannie Willis. Willis was disqualified because of an appearance of impropriety stemming from an intimate relationship with a lead investigative prosecutor. schools in the Charlotte, North Carolina area are reassuring families after news that border patrol agents will soon be arriving in the city. James Farrell of Member Station WFAE has more on the district's message to the community. Charlotte Mecklenburg Schools says the district hasn't been notified of any planned enforcement activity. CMS board member Liz Monterey Duvall says she's concerned about children
Starting point is 00:00:52 from immigrant families missing school. It's devastating. I'm a daughter of immigrants and I'm very protective of our students and our kids, and I'm worried about absenteeism and learning laws. CMS says it follows federal and state laws that guarantee all children the right to public education regardless of immigration status. Latinos make up the second largest group of CMS students. For NPR News, I'm James Farrell and Charlotte. A national institutes of health employee who has been criticized, or has criticized, rather, Trump administration health policies has been put on leave. NPR's Rob Stein reports on the action against the employee. The NIH put Jenna Norton on indefinite paid administrative leave on her first day back to work from the government shutdown.
Starting point is 00:01:37 Norton, a program director at the National Institute of Diabetes and Digestive and Kidney Diseases, has been a vocal critic of cuts and new policies at the NIH. The NIH should not give Norton an explanation, but in a statement to NPR, an administration of officials said, quote, instead of focusing on her actual job to promote gold standard science, radical leftist Jenna Norton chooses to constantly criticize this administration, even when she's supposed to be working, unquote. Rob Stein, NPR News. The Trump administration has been discussing this week how to reduce prices on household items such as coffee. Harvest Public Media's Skylo Rossi explains how tariffs have put a
Starting point is 00:02:22 squeeze on coffee shops. Broadway roasting company in Kansas City, Missouri, roast coffee from all over the world. Co-owner John Kate says he's paid at least a 10% tariff on most of the coffee beans he's purchased this year. We've been in business for 30 years and we've never seen anything like this before. Where you raise your price and it's for no reason other than to stay in business. The cost of a pound of ground coffee at the grocery store has climbed to a record $9.14 in September. America gets much of its coffee from Brazil, which currently has a 50% tariff. That's Skylarossa reporting. It's NPR News.
Starting point is 00:03:01 The CEO credited with expanding Walmart's economic and technological footprint over the last decade is leaving the company. Today, Walmart announced that Doug McMillan, who is 59, plans to retire early next year. As of February, John Ferner, the 51-year-old head of Walmart, U.S. operations will take the reins of the retail giant. Both executives have been with Walmart their entire careers. McMillan may not be leaving the company anytime soon. He is expected to remain on the board. A new survey shows one in eight adults in the U.S. is currently taking the drug Ozempic, Wagovi, or similar weight loss medications. NPR Sidney Lepkin reports that's according to the nonpartisan research organization, KFF.
Starting point is 00:03:50 The number of adults taking GLP1 drugs, which include Ozympic, Wagovi, Zepound, and Manjaro, is going up. It went from 6% a year and a half ago to 12% now. People are taking the drugs for chronic conditions like type 2 diabetes and heart disease, as well as for weight loss. Here's Ashley Kurtzinger, a pollster at KFF. What was really striking to us that there wasn't one demographic group that was kind of driving the increase. It looked like there was a pretty steady increase in use across demographic groups. Although most people taking these drugs say they have some insurance coverage for them, more than half say the drugs are difficult to afford. KFF conducted the poll between
Starting point is 00:04:32 October 27th and November 2nd. Sydney Lubkin, NPR News. I'm Lakshmi Singh, NPR News.

There aren't comments yet for this episode. Click on any sentence in the transcript to leave a comment.